Cee-500 Disease Interactions
There are 4 disease interactions with Cee-500 (ascorbic acid).
Ascorbic acid (vitamin C) (applies to Cee-500) hemolysis
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: G-6-PD Deficiency
Acute hemolysis following administration of high doses of ascorbic acid in patients with glucose-6-phosphate deficiency (G6PD) has been reported. Ascorbic acid should be administered cautiously and dosages modified in patients with G6PD.
Ascorbic acid (vitamin C) (applies to Cee-500) kidney stones
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Nephrolithiasis
Large doses of ascorbic acid have lead to hyperoxaluria in 5% of patients. Ascorbic acid can acidify urine resulting in precipitation of urate, cystine, or oxalate stones. Ascorbic acid should be administered cautiously and dosages modified in patients predisposed to renal stones. Clinical monitoring of urinalysis for pH and crystal formation is recommended.
Ascorbic acid (vitamin C) (applies to Cee-500) sodium
Moderate Potential Hazard, Low plausibility. Applicable conditions: Hypernatremia, Hypertension
Ascorbic acid preparations contain sodium. The sodium content should be considered when used in patients with sodium restricted diets and conditions require sodium restriction, such as congestive heart failure, hypertension, and fluid retention.
Ascorbic acid (vitamin C) (applies to Cee-500) dialysis
Minor Potential Hazard, High plausibility. Applicable conditions: hemodialysis
Ascorbic acid is removed by dialysis.
Cee-500 drug interactions
There are 30 drug interactions with Cee-500 (ascorbic acid).
Cee-500 alcohol/food interactions
There is 1 alcohol/food interaction with Cee-500 (ascorbic acid).
More about Cee-500 (ascorbic acid)
- Cee-500 consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: vitamins
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.